Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases
Journal of Clinical Oncology, 09/14/09
Rose PS et al. – Vertebral fracture is common after single fraction IG-IMRT for metastatic spine lesions. Lytic disease involving more than 40% of the vertebral body and location at or below T10 confer a high risk of fracture, the presence of which yields significantly poorer clinical outcomes. These results may help identify high-risk patients who would benefit from prophylactic vertebro- or kypho-plasty.
Methods- 62 consecutive patients
- Single fraction IG-IMRT
- 71 sites for solid organ metastases
- Prospectively obtained magnetic resonance/ CT imaging studies evaluated for post-treatment fracture development and tumor recurrence
- Fracture progression noted in 27 vertebrae
- Multivariate logistic regression analysis showed CT appearance, lesion location, and percent vertebral body involvement independently predicted fracture progression
- Lesions located between T10 and sacrum 4.6 times more likely to fracture than lesions above T10
- Lytic lesions 6.8 times more likely to fracture than sclerotic and mixed lesions
- As percent vertebral body involvement increased, fracture risk increased
- Patients with fracture progression had higher narcotic use, change in Karnofsky performance score, and trend toward higher pain scores
- Local tumor progression in seven patients
- Local tumor progression contributed to one fracture
- Obesity, posterior element involvement, bisphosphonate use, and local kyphosis did not increase risk
Related Articles
Survival Rate and Neurological Outcome after Operation for Advanced Spinal Metastasis (Tomita's Classification >= Type 4)
Yonsei Medical Journal, 10/29/09
Relevance Score: 67%
A Prospective, Phase II Study Demonstrating the Potential Value and Limitation of Radiosurgery for Spine Metastases
American Journal of Clinical Oncology, 10/06/09
Relevance Score: 67%
Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers
Annals of Surgical Oncology, 10/26/09
Relevance Score: 64%
Percutaneous CT-Guided Vertebroplasty in the Management of Osteoporotic Fractures and Dorsolumbar Metastases
Orthopedic Clinics of North America, 10/05/09
Relevance Score: 64%
Holistic view of Chinese spinal manipulation and its clinical application
Journal of Acupuncture and Tuina Science, 10/20/09
Relevance Score: 47%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Toxicity of Bisphosphonates
Journal of Palliative Medicine, 11/20/09
Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis
Clinical Cancer Research, 11/20/09
Gene Expression Profiles Classify Human Osteosarcoma Xenografts According to Sensitivity to Doxorubicin, Cisplatin, and Ifosfamide
Clinical Cancer Research, 11/20/09
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients
Evidence-based Complementary and Alternative Medicine , 11/20/09
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-2a compared with sunitinib
British Journal of Cancer, 11/20/09
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer
Cancer, 11/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


